"This state-of-the-art equipment will enable Kelyniam to produce certain medical models on the same 24-hour turnaround schedule we offer for cranial implants," said Chris Breault, Kelyniam's Chief Operating Officer. "The ability to rapidly print ultrahigh resolution models with high accuracy across our entire platform is a significant differentiator in our industry."
The use of medical models to assist surgeons' preparation for complex procedures is becoming the clinical standard for many types of surgeries.
"Medical models allow the surgeon to better visualize the specific technique planned for the surgery," said Vice President of Sales and Business Development, Dr. Mark Smith. "When the model is customized to the patient's unique physical structure, the surgeon may determine a safer or more efficient surgical plan, resulting in shorter surgery times and potentially better outcomes."
The new additive manufacturing technology is in perfect alignment with Kelyniam's reputation as the preferred cranial implant supplier when rapid turn around and design excellence is required.
Kelyniam Inc., specializes in the rapid production of custom prosthetics and medical models utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The Company develops, manufactures, and distributes custom cranial and maxillo-facial implants for patients requiring the reconstruction of cranial and certain facial structures. Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site address is www.Kelyniam.com.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of ability to market products; and the risks described from time to time in the Company's SEC reports.
SOURCE Kelyniam Global, Inc.
|Company Name: Kelyniam Global, Inc.
Chris Breault, COO, Kelyniam Inc., (800) 280 - 8192
Financial data for Kelyniam Global, Inc.